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We read with interest the disorders of consciousness guideline1 but found issues with the rec-
ommendations. Some of the recommendations are classified as level A (recommendations 3, 9,
and 11). For example, “When prognosis is poor, long-term care must be discussed (level A)….”1
The references cited did not come from a randomized control trial. Typically, level A is based on
one or more randomized control trial and is prefaced by a statement about the class of evidence.
We cannot find references to any trials on which these recommendations were made.1,2 Can the
authors reassess the use of the level of recommendation in this guideline?
Editors’note: Practice guidelineupdate recommendations summary:
Disorders of consciousness: Report of the Guideline Development,
Dissemination, and Implementation Subcommittee of the American
Academy of Neurology; the American Congress of Rehabilitation
Medicine; and the National Institute on Disability, Independent
Living, and Rehabilitation Research
In their American Academy of Neurology (AAN) practice parameter, Giacino et al. pro-
vided a thorough review of the available evidence pertaining to the care of patients with
impaired consciousness. The expert panel provided level of recommendations (LORs)
regarding the discussion of long-term care needs, pain management strategies, and tech-
niques for neuroprognostication in patients with disorders of consciousness. In response to
these consensus recommendations, Phan et al. highlight 1 potential limitation of the LOR
classification system that was used. Historically, the highest LOR (level A) was afforded
only to recommendations based on 1 or more randomized clinical trials. However, this
requirement was amended by the Institute of Medicine in 2011 as well as the 2011 AAN
Clinical Guideline Practice Manual, as the authors emphasize in their response. After 2011,
a level A recommendation was permitted as long as there was strong and consistent related
evidence and inferences could be drawn. Therefore, a higher LOR could be assigned to
recommendations with less explicit substantiation from large randomized clinical trials. By
using this classification schema, some recommendations may be generalized to patients
who are likely to benefit from such guidance.
James E. Siegler III, MD, and Steven Galetta, MD
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American Academy of Neurology (AAN) guidelines comply with the AAN Institute
Board-approved guideline methodology referenced within the systematic review/
guideline.1,2 Compliance is ensured by a methodologist working on each project and
multiple rounds of AAN Guideline Development, Dissemination, and Implementation Sub-
committee review. We believe that Phan et al. are referencing the 2004 recommendation meth-
odology.3 The disorders of consciousness guideline used the 2011 AAN guideline manual, as
amended,4 based on 2011 Institute ofMedicine (IOM) standards for evidence-based guidelines.5 In
this process, recommendations are based not only on a systematic review of the evidence but also on
strongly related evidence, principles of care, and inferences. The level of obligation for each rec-
ommendation is determined by the strength of these premises and a risk–benefit assessment, with
adjustments based on outcome importance, patient preference variability, feasibility/availability, and
patient costs. Consensus is determined by a modified Delphi voting process in accordance with
prespecified rules, as described in the systematic review.2 This IOM-compliant approach improves
recommendation usability. The modified Delphi tables and the premise types for each recom-
mendation rationale are available in the online appendices, NPub.org/m5ii8i (“rationale profiles”
for recommendations 3, 9, and 11 are on pages 190, 204, and 206, respectively).
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In the Resident & Fellow Clinical Reasoning paper by Rossi et al.,1 the authors described an
unusual case of Bálint syndrome caused by focal nonconvulsive status epilepticus in a patient
with cirrhosis and hyponatremia. I am curious about the nature of the clinical finding: “…
horizontal nystagmus in all directions including on primary gaze.”1
Horizontal nystagmus in all directions localizes to the brainstem/cerebellum; however, in this
case,1 the lesions were parieto-occipital. Hyponatremia, if accompanied by hypomagnesemia,
would cause a downbeat nystagmus. Could the nystagmus thus be an epileptic nystagmus of
cortical origin? The bilaterality of the epileptic foci might explain the bilateral direction of the
nystagmus. The authors describe an intermittent eye deviation on video during EEG recording;
the mechanism is, therefore, probably due to epileptic alternative eye deviation with quick
corrective saccades. It would be interesting to know the direction of the nystagmus, since this
may elucidate whether the underlying activated mechanism of the eye deviations was saccadic
or pursuit. Furthermore, the finding of a normal optokinetic nystagmus in Bálint syndrome and
during seizures is mostly unusual. Also, can the authors please comment on the radiologic
follow-up of this patient as the parieto-occipital T2 hyperintensities should resolve with time if
attributed to seizure activity?
1. Rossi KC, Brandstadter R, Fields MC, Leong J, Shin S. Clinical Reasoning: a 54-year-old woman with confusion and visual disturbances.
Neurology 2018;91:363–367.
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Editors’ note: Clinical Reasoning: A 54-year-old woman with
confusion and visual disturbances
Rossi et al. presented the unusual case of a 54-year-old woman with cirrhosis who de-
veloped oculomotor apraxia, optic ataxia, impaired smooth pursuit, and horizontal nys-
tagmus in all directions of gaze. The neuroimaging and electrographic diagnosis was
nonconvulsive status epilepticus resulting in Bálint syndrome. Dr. Pollak also suspects an
epileptic origin of the horizontal, alternating nystagmus pattern, given the bilateralMRI and
EEG findings. However, Dr. Pollack notes that a normal optokinetic nystagmus would be
unusual during seizure activity. Rossi et al. attribute this to the fluctuating nature of the
patient’s condition and the intermittent epileptiform activity on EEG. Resolution of the
cortical diffusion abnormalities on MRI would also have supported seizures as the cause of
the patient’s symptoms, as Dr. Pollak writes. Unfortunately, this could not be confirmed as
the patient was lost to follow-up.
James E. Siegler III, MD, and Steven Galetta, MD
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We thank Dr. Pollak for the thoughtful comments on our article.1 The nature of the nystagmus
was variable over the clinical course. Our earliest notes described direction-changing horizontal
gaze-evoked nystagmus on left and right end gaze and primary gaze. The mechanism of
epileptic nystagmus is poorly understood with most available literature being from case reports,
often reporting the fast phase of nystagmus away from the seizure focus.2–4 Here, the bilateral
foci could explain the direction changing nature of the nystagmus. Of note, the case was
confounded by metabolic derangements, potentially contributing to brainstem dysfunction and
eye movement abnormalities. Although epileptic nystagmus is possible, it is difficult to con-
clude with certainty.
The intact optokinetic nystagmus (OKN) reflex could be related to the fluctuating nature of the
symptoms given an epileptic origin as opposed to a fixed structural origin. Additionally, Baloh
et al.5 reported on the structural pathways involved in the OKN reflex, suggesting a complicated
2-pathway mechanism and showing that many parietal lesions do not obliterate all parts of the
OKN response uniformly.
Regarding follow-up imaging, the patient was unfortunately lost to follow-up from a neurology
perspective; the plan for follow-up imaging was not completed at our institution.
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CORRECTION
Quality of life predicts outcome of deep brain stimulation in early
Parkinson disease
Neurology® 2019;92:1166. doi:10.1212/WNL.0000000000007420
In the article “Quality of life predicts outcome of deep brain stimulation in early Parkinson
disease” by Schuepbach et al.,1 published online ahead of print on February 8, 2019,
Dr. Hälbig’s name should have included a middle initial: Thomas D. Hälbig. The corrected
name appears in the March 5 issue. The editorial office regrets the error.
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